Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High fructose exposure modifies the amount of adipocyte-secreted microRNAs into extracellular vesicles in supernatants and plasma.
Hernández-Díazcouder A, González-Ramírez J, Giacoman-Martínez A, Cardoso-Saldaña G, Martínez-Martínez E, Osorio-Alonso H, Márquez-Velasco R, Sánchez-Gloria JL, Juárez-Vicuña Y, Gonzaga G, Sánchez-Lozada LG, Almanza-Pérez JC, Sánchez-Muñoz F. Hernández-Díazcouder A, et al. Among authors: giacoman martinez a. PeerJ. 2021 May 19;9:e11305. doi: 10.7717/peerj.11305. eCollection 2021. PeerJ. 2021. PMID: 34055478 Free PMC article.
Glycine is a competitive antagonist of the TNF receptor mediating the expression of inflammatory cytokines in 3T3-L1 adipocytes.
Romero-Nava R, Alarcón-Aguilar FJ, Giacoman-Martínez A, Blancas-Flores G, Aguayo-Cerón KA, Ballinas-Verdugo MA, Sánchez-Muñoz F, Huang F, Villafaña-Rauda S, Almanza-Pérez JC. Romero-Nava R, et al. Among authors: giacoman martinez a. Inflamm Res. 2021 May;70(5):605-618. doi: 10.1007/s00011-021-01462-1. Epub 2021 Apr 20. Inflamm Res. 2021. PMID: 33877377
Synthesis, molecular docking, dynamic simulation and pharmacological characterization of potent multifunctional agent (dual GPR40-PPARγ agonist) for the treatment of experimental type 2 diabetes.
Hidalgo-Figueroa S, Rodríguez-Luévano A, Almanza-Pérez JC, Giacoman-Martínez A, Ortiz-Andrade R, León-Rivera I, Navarrete-Vázquez G. Hidalgo-Figueroa S, et al. Among authors: giacoman martinez a. Eur J Pharmacol. 2021 Sep 15;907:174244. doi: 10.1016/j.ejphar.2021.174244. Epub 2021 Jun 8. Eur J Pharmacol. 2021. PMID: 34116041
Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds.
Herrera-Rueda MÁ, Tlahuext H, Paoli P, Giacoman-Martínez A, Almanza-Pérez JC, Pérez-Sánchez H, Gutiérrez-Hernández A, Chávez-Silva F, Dominguez-Mendoza EA, Estrada-Soto S, Navarrete-Vazquez G. Herrera-Rueda MÁ, et al. Biomed Pharmacother. 2018 Dec;108:670-678. doi: 10.1016/j.biopha.2018.09.074. Epub 2018 Sep 21. Biomed Pharmacother. 2018. PMID: 30245467 Free article.
Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids.
Colín-Lozano B, Estrada-Soto S, Chávez-Silva F, Gutiérrez-Hernández A, Cerón-Romero L, Giacoman-Martínez A, Almanza-Pérez JC, Hernández-Núñez E, Wang Z, Xie X, Cappiello M, Balestri F, Mura U, Navarrete-Vazquez G. Colín-Lozano B, et al. Molecules. 2018 Feb 6;23(2):340. doi: 10.3390/molecules23020340. Molecules. 2018. PMID: 29415496 Free PMC article.
Discovery of new dual PPARγ-GPR40 agonists with robust antidiabetic activity: Design, synthesis and in combo drug evaluation.
Hidalgo-Figueroa S, Navarrete-Vázquez G, Estrada-Soto S, Giles-Rivas D, Alarcón-Aguilar FJ, León-Rivera I, Giacoman-Martínez A, Miranda Pérez E, Almanza-Pérez JC. Hidalgo-Figueroa S, et al. Biomed Pharmacother. 2017 Jun;90:53-61. doi: 10.1016/j.biopha.2017.03.033. Epub 2017 Mar 22. Biomed Pharmacother. 2017. PMID: 28342366
16 results